Effectiveness of adjuvant chemotherapy for elderly patients with triple-negative breast cancer

There is little evidence determining whether elderly patients (from 70 to 90 years old) with triple-negative breast cancer (TNBC) could benefit from adjuvant chemotherapy (AC). This study explores the effect of AC in these population following surgery. A total of 4610 patients were identified in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Qiusheng, Lan, Tian, Lu, Yunyan, Hu, Zujian, Xu, Haibin, Wang, Xiaojia, Shao, Xiying, Fu, Xueyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171436/
https://www.ncbi.nlm.nih.gov/pubmed/36408954
http://dx.doi.org/10.17305/bjbms.2022.8163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171436/
https://www.ncbi.nlm.nih.gov/pubmed/36408954
http://dx.doi.org/10.17305/bjbms.2022.8163

Ejemplares similares